Vimarsana
Biggest News Aggregation in the World

Page 30 - Jay Roberts News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jay Roberts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jay Roberts Today - Breaking & Trending Today

Vyant Bio enters collaboration with Organo Therapeutics to find treatments for Parkinson's Disease - Vimarsana News

Vyant Bio enters collaboration with Organo Therapeutics to find treatments for Parkinson's Disease

Vyant Bio (NASDAQ:VYNT) Inc CEO Jay Roberts and chief scientific officer Robert Fremeau tells Proactive it has entered into a collaboration agreement with...

Vyant Bio Inc enters collaboration with OrganoTherapeutics to find treatments for Parkinson's Disease - Vimarsana News

Vyant Bio Inc enters collaboration with OrganoTherapeutics to find treatments for Parkinson's Disease

Vyant Bio (NASDAQ:VYNT) Inc said it has entered into a collaboration agreement with OrganoTherapeutics to accelerate the discovery of drugs to treat...

Vyant Bio Inc ends 2021 with $20.6M in cash as it sharpens focus on novel drug discovery - Vimarsana News

Vyant Bio Inc ends 2021 with $20.6M in cash as it sharpens focus on novel drug discovery

Vyant Bio (NASDAQ:VYNT) Inc said it ended its 2021 financial year with a beefed-up cash balance of $20.6 million to help the biotechnology company pursue...

Vyant Bio and OrganoTherapeutics Announce Strategic - Vimarsana News

Vyant Bio and OrganoTherapeutics Announce Strategic

Cherry Hill, N.J. and Esch-sur-Alzette, Luxembourg, March 29, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an...

Vyant Bio and OrganoTherapeutics Announce Strategic Collaboration to Discover Therapeutics to ... - Vimarsana News

Vyant Bio and OrganoTherapeutics Announce Strategic Collaboration to Discover Therapeutics to ...

Cherry Hill, N.J. and Esch-sur-Alzette, Luxembourg, March 29, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental